FFA
TSVT

Fairfield Financial Advisors’s 2seventy bio TSVT Stock Holding History

Fairfield Financial Advisors’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20
Closed -$59 – 190
2024
Q4 		$59 Hold
20
– – ﹤0.01% 262
2024
Q3 		$94 Hold
20
– – ﹤0.01% 288
2024
Q2 		$77 Buy
+20
New +$90 ﹤0.01% 288
2023
Q4 		$85 Hold
20
– – ﹤0.01% 310
2023
Q3 		$78 Hold
20
– – ﹤0.01% 299
2023
Q2 		$202 Hold
20
– – ﹤0.01% 307
2023
Q1 		$198 Hold
20
– – ﹤0.01% 313
2022
Q4 		$187 Hold
20
– – ﹤0.01% 305
2022
Q3 		$291 Hold
20
– – ﹤0.01% 315
2022
Q2 		$264 Hold
20
– – ﹤0.01% 299
2022
Q1 		$341 Buy
+20
New +$339 ﹤0.01% 301

Other funds holding TSVT

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Fairfield Financial Advisors's TSVT Position: Q1 2025 in Review

Fairfield Financial Advisors sold out of 2seventy bio (TSVT) in Q1 2025, closing a stake of 20 shares — an estimated $59 sold.

Fairfield Financial Advisors first reported a position in TSVT in Q1 2022 and held it in 11 quarters. The position peaked at $341 in Q1 2022. 139 funds tracked by Wall St. Rank hold TSVT as of Q1 2025.

  • Fairfield Financial Advisors reported no remaining 2seventy bio position as of Q1 2025 after selling out during the quarter.
  • Fairfield Financial Advisors sold 20 2seventy bio shares in Q1 2025, an estimated $59.
  • Fairfield Financial Advisors first reported a position in 2seventy bio in Q1 2022 and held it in 11 quarters.
  • Fairfield Financial Advisors's 2seventy bio position peaked at $341 in Q1 2022.
  • 139 funds tracked by Wall St. Rank held 2seventy bio as of Q1 2025.

Based on Fairfield Financial Advisors's 13F filing for Q1 2025, filed 9 May 2025.